Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Killer Cells, Natural"" wg kryterium: Temat


Tytuł :
Pilot study to determine the safety and feasibility of deceased donor liver natural killer cell infusion to liver transplant recipients with hepatocellular carcinoma.
Autorzy :
Ohira M; Department of Gastroenterological and Transplant Surgery, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.; Department of Surgery, Division of Liver and Gastrointestinal Transplantation, University of Miami Miller School of Medicine, Miami, FL, USA.; Medical Center for Translational and Clinical Research, Hiroshima University Hospital, Hiroshima, Japan.
Hotta R; Department of Gastroenterological and Transplant Surgery, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.; Department of Surgery, Division of Liver and Gastrointestinal Transplantation, University of Miami Miller School of Medicine, Miami, FL, USA.
Tanaka Y; Department of Gastroenterological and Transplant Surgery, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
Matsuura T; Department of Surgery, Division of Liver and Gastrointestinal Transplantation, University of Miami Miller School of Medicine, Miami, FL, USA.
Tekin A; Department of Surgery, Division of Liver and Gastrointestinal Transplantation, University of Miami Miller School of Medicine, Miami, FL, USA.
Selvaggi G; Department of Surgery, Division of Liver and Gastrointestinal Transplantation, University of Miami Miller School of Medicine, Miami, FL, USA.
Vianna R; Department of Surgery, Division of Liver and Gastrointestinal Transplantation, University of Miami Miller School of Medicine, Miami, FL, USA.
Ricordi C; Cell Transplant Center, Diabetes Research Institute, University of Miami Miller School of Medicine, Miami, FL, USA.
Ruiz P; Department of Pathology and Surgery, University of Miami Miller School of Medicine, Miami, FL, USA.
Nishida S; Department of Surgery, Division of Liver and Gastrointestinal Transplantation, University of Miami Miller School of Medicine, Miami, FL, USA.; Department of Surgery, Westchester Medical Center, New York Medical College, Valhalla, NY, USA.
Tzakis AG; Department of Surgery, Division of Liver and Gastrointestinal Transplantation, University of Miami Miller School of Medicine, Miami, FL, USA. .; Transplant Center, Cleveland Clinic, Cleveland, OH, USA. .; Transplant Center, Cleveland Clinic Florida, Weston, FL, USA. .
Ohdan H; Department of Gastroenterological and Transplant Surgery, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan. .
Pokaż więcej
Źródło :
Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2022 Mar; Vol. 71 (3), pp. 589-599. Date of Electronic Publication: 2021 Jul 19.
Typ publikacji :
Journal Article
MeSH Terms :
Liver Transplantation*/adverse effects
Liver Transplantation*/methods
Carcinoma, Hepatocellular/*therapy
Killer Cells, Natural/*immunology
Killer Cells, Natural/*transplantation
Liver/*immunology
Liver Neoplasms/*therapy
Adoptive Transfer ; Adult ; Aged ; Biomarkers ; Combined Modality Therapy ; Feasibility Studies ; Female ; Graft Survival ; Humans ; Immunohistochemistry ; Killer Cells, Natural/metabolism ; Male ; Middle Aged ; Pilot Projects ; Treatment Outcome ; Young Adult
Czasopismo naukowe
Tytuł :
Expansion of cytotoxic natural killer cells in multiple myeloma patients using K562 cells expressing OX40 ligand and membrane-bound IL-18 and IL-21.
Autorzy :
Thangaraj JL; Research Center for Cancer Immunotherapy, Gwangju, South Korea.; Department of Hematology-Oncology, Chonnam National University Hwasun Hospital, 322 Seoyangro, Hwasun, Jeollanamdo, 519-763, Republic of Korea.; Department of Molecular Medicine, Chonnam National University, Gwangju, South Korea.
Phan MT; Stem Cell & Regenerative Medicine Institute, Samsung Medical Center, Seoul, South Korea.
Kweon S; Stem Cell & Regenerative Medicine Institute, Samsung Medical Center, Seoul, South Korea.; School of Interdisciplinary Bioscience and Bioengineering (I-Bio), POSTECH, Pohang, South Korea.
Kim J; Stem Cell & Regenerative Medicine Institute, Samsung Medical Center, Seoul, South Korea.; Department of Health Sciences and Technology, SAIHST, Sungkyunkwan University, Seoul, South Korea.
Lee JM; Bio Research Center, Lugensci Co. Ltd., Bucheon, South Korea.
Hwang I; Department of Emergency Medicine, Konkuk University Chungju Hospital, Chungju, South Korea.
Park J; Research Institute of Advanced Materials, Seoul National University, Seoul, South Korea.
Doh J; Department of Materials Science and Engineering, Seoul National University, Seoul, South Korea.
Lee SH; Department of Biochemistry, Microbiology and Immunology, Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada.
Vo MC; Research Center for Cancer Immunotherapy, Gwangju, South Korea.; Department of Hematology-Oncology, Chonnam National University Hwasun Hospital, 322 Seoyangro, Hwasun, Jeollanamdo, 519-763, Republic of Korea.
Chu TH; Research Center for Cancer Immunotherapy, Gwangju, South Korea.; Department of Molecular Medicine, Chonnam National University, Gwangju, South Korea.
Song GY; Research Center for Cancer Immunotherapy, Gwangju, South Korea.; Department of Hematology-Oncology, Chonnam National University Hwasun Hospital, 322 Seoyangro, Hwasun, Jeollanamdo, 519-763, Republic of Korea.
Ahn SY; Research Center for Cancer Immunotherapy, Gwangju, South Korea.; Department of Hematology-Oncology, Chonnam National University Hwasun Hospital, 322 Seoyangro, Hwasun, Jeollanamdo, 519-763, Republic of Korea.
Jung SH; Research Center for Cancer Immunotherapy, Gwangju, South Korea.; Department of Hematology-Oncology, Chonnam National University Hwasun Hospital, 322 Seoyangro, Hwasun, Jeollanamdo, 519-763, Republic of Korea.
Kim HJ; Department of Hematology-Oncology, Chonnam National University Hwasun Hospital, 322 Seoyangro, Hwasun, Jeollanamdo, 519-763, Republic of Korea.
Cho D; Stem Cell & Regenerative Medicine Institute, Samsung Medical Center, Seoul, South Korea. .; Department of Health Sciences and Technology, SAIHST, Sungkyunkwan University, Seoul, South Korea. .; Department of Laboratory Medicine and Genetics, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-dong, Gangnam-gu, Seoul, 06351, Republic of Korea. .
Lee JJ; Research Center for Cancer Immunotherapy, Gwangju, South Korea. .; Department of Hematology-Oncology, Chonnam National University Hwasun Hospital, 322 Seoyangro, Hwasun, Jeollanamdo, 519-763, Republic of Korea. .; Department of Molecular Medicine, Chonnam National University, Gwangju, South Korea. .
Pokaż więcej
Źródło :
Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2022 Mar; Vol. 71 (3), pp. 613-625. Date of Electronic Publication: 2021 Jul 20.
Typ publikacji :
Journal Article
MeSH Terms :
Cytotoxicity, Immunologic*/genetics
Interleukin-18/*metabolism
Interleukins/*metabolism
Killer Cells, Natural/*immunology
Lymphocyte Activation/*immunology
Multiple Myeloma/*immunology
OX40 Ligand/*metabolism
Cells, Cultured ; Coculture Techniques ; Gene Expression ; Humans ; Immunophenotyping ; Interleukin-18/genetics ; Interleukins/genetics ; K562 Cells ; Killer Cells, Natural/cytology ; Killer Cells, Natural/metabolism ; OX40 Ligand/genetics ; Transduction, Genetic ; Transgenes
Czasopismo naukowe
Tytuł :
Differential expression of disparate transcription factor regime holds the key for NK cell development and function modulation.
Autorzy :
Rawat P; Department of Biotechnology, Delhi Technological University, Main Bawana Road, Delhi 110042, India.
Das A; Department of Biotechnology, Delhi Technological University, Main Bawana Road, Delhi 110042, India. Electronic address: .
Pokaż więcej
Źródło :
Life sciences [Life Sci] 2022 May 15; Vol. 297, pp. 120471. Date of Electronic Publication: 2022 Mar 09.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Killer Cells, Natural*
Transcription Factors*/metabolism
Female ; Gene Expression Regulation ; Humans ; Pregnancy ; Spleen/metabolism ; Uterus/metabolism
Czasopismo naukowe
Tytuł :
Intracellular infection and immune system cues rewire adipocytes to acquire immune function.
Autorzy :
Caputa G; Department of Immunometabolism, Max Planck Institute for Immunobiology and Epigenetics, 79108 Freiburg, Germany.
Matsushita M; Department of Immunometabolism, Max Planck Institute for Immunobiology and Epigenetics, 79108 Freiburg, Germany.
Sanin DE; Department of Immunometabolism, Max Planck Institute for Immunobiology and Epigenetics, 79108 Freiburg, Germany; Bloomberg Kimmel Institute, and Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.
Kabat AM; Department of Immunometabolism, Max Planck Institute for Immunobiology and Epigenetics, 79108 Freiburg, Germany.
Edwards-Hicks J; Department of Immunometabolism, Max Planck Institute for Immunobiology and Epigenetics, 79108 Freiburg, Germany.
Grzes KM; Department of Immunometabolism, Max Planck Institute for Immunobiology and Epigenetics, 79108 Freiburg, Germany.
Pohlmeyer R; Imaging Facility, Max Planck Institute for Immunobiology and Epigenetics, 79108 Freiburg, Germany.
Stanczak MA; Department of Immunometabolism, Max Planck Institute for Immunobiology and Epigenetics, 79108 Freiburg, Germany.
Castoldi A; Department of Immunometabolism, Max Planck Institute for Immunobiology and Epigenetics, 79108 Freiburg, Germany.
Cupovic J; Department of Immunometabolism, Max Planck Institute for Immunobiology and Epigenetics, 79108 Freiburg, Germany.
Forde AJ; Faculty of Biology, University of Freiburg, 79104 Freiburg, Germany; Center for Chronic Immune Deficiency, Faculty of Medicine, University of Freiburg, 79104 Freiburg, Germany.
Apostolova P; Department of Immunometabolism, Max Planck Institute for Immunobiology and Epigenetics, 79108 Freiburg, Germany.
Seidl M; Center for Chronic Immune Deficiency, Faculty of Medicine, University of Freiburg, 79104 Freiburg, Germany; Institute of Surgical Pathology, Faculty of Medicine, Medical Center, University of Freiburg, 79104 Freiburg, Germany; Institute of Pathology, Heinrich Heine University and University Hospital of Duesseldorf, 40225 Duesseldorf, Germany.
van Teijlingen Bakker N; Department of Immunometabolism, Max Planck Institute for Immunobiology and Epigenetics, 79108 Freiburg, Germany; Faculty of Biology, University of Freiburg, 79104 Freiburg, Germany.
Villa M; Department of Immunometabolism, Max Planck Institute for Immunobiology and Epigenetics, 79108 Freiburg, Germany.
Baixauli F; Department of Immunometabolism, Max Planck Institute for Immunobiology and Epigenetics, 79108 Freiburg, Germany.
Quintana A; Department of Immunometabolism, Max Planck Institute for Immunobiology and Epigenetics, 79108 Freiburg, Germany.
Hackl A; Department of Immunometabolism, Max Planck Institute for Immunobiology and Epigenetics, 79108 Freiburg, Germany.
Flachsmann L; Department of Immunometabolism, Max Planck Institute for Immunobiology and Epigenetics, 79108 Freiburg, Germany.
Hässler F; Department of Immunometabolism, Max Planck Institute for Immunobiology and Epigenetics, 79108 Freiburg, Germany.
Curtis JD; Department of Immunometabolism, Max Planck Institute for Immunobiology and Epigenetics, 79108 Freiburg, Germany.
Patterson AE; Department of Immunometabolism, Max Planck Institute for Immunobiology and Epigenetics, 79108 Freiburg, Germany.
Henneke P; Center for Chronic Immune Deficiency, Faculty of Medicine, University of Freiburg, 79104 Freiburg, Germany.
Pearce EL; Department of Immunometabolism, Max Planck Institute for Immunobiology and Epigenetics, 79108 Freiburg, Germany; Bloomberg Kimmel Institute, and Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA; Department of Biochemistry and Molecular Biology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD 21287, USA. Electronic address: .
Pearce EJ; Department of Immunometabolism, Max Planck Institute for Immunobiology and Epigenetics, 79108 Freiburg, Germany; Faculty of Biology, University of Freiburg, 79104 Freiburg, Germany; Bloomberg Kimmel Institute, and Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA; Department of Molecular Microbiology and Immunology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD 21287, USA. Electronic address: .
Pokaż więcej
Źródło :
Cell metabolism [Cell Metab] 2022 May 03; Vol. 34 (5), pp. 747-760.e6.
Typ publikacji :
Journal Article
MeSH Terms :
Cues*
Killer Cells, Natural*
Adipocytes/metabolism ; Immunity ; Interferon-gamma/metabolism
Czasopismo naukowe
Tytuł :
The CD3ζ adaptor structure determines functional differences between human and mouse CD16 Fc receptor signaling.
Autorzy :
Aguilar OA; Department of Microbiology and Immunology, University of California, San Francisco, San Francisco, CA.; Parker Institute for Cancer Immunotherapy, University of California, San Francisco, San Francisco, CA.
Fong LK; Department of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, CA.
Ishiyama K; Department of Microbiology and Immunology, University of California, San Francisco, San Francisco, CA.
DeGrado WF; Department of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, CA.
Lanier LL; Department of Microbiology and Immunology, University of California, San Francisco, San Francisco, CA.; Parker Institute for Cancer Immunotherapy, University of California, San Francisco, San Francisco, CA.
Pokaż więcej
Źródło :
The Journal of experimental medicine [J Exp Med] 2022 May 02; Vol. 219 (5). Date of Electronic Publication: 2022 Mar 23.
Typ publikacji :
Journal Article
MeSH Terms :
CD3 Complex*/genetics
Killer Cells, Natural*
Receptors, IgG*/genetics
Animals ; GPI-Linked Proteins ; Humans ; Mice ; Receptors, Fc ; Signal Transduction
Czasopismo naukowe
Tytuł :
A Single-Domain TCR-like Antibody Selective for the Qa-1 /Qdm Peptide Complex Enhances Tumoricidal Activity of NK Cells via Blocking the NKG2A Immune Checkpoint.
Autorzy :
Ghaffari S; Department of Biology, College of Science, The University of Texas at Arlington, Arlington, TX.
Upchurch-Ange K; Abexxa Biologics, Inc., Arlington, TX.
Gimlin S; Abexxa Biologics, Inc., Arlington, TX.
Tripathi T; Abexxa Biologics, Inc., Arlington, TX.
Sluijter M; Department of Medical Oncology, Oncode Institute, Leiden University Medical Center, Leiden, the Netherlands; and.
Middelburg J; Department of Medical Oncology, Oncode Institute, Leiden University Medical Center, Leiden, the Netherlands; and.
van Hall T; Department of Medical Oncology, Oncode Institute, Leiden University Medical Center, Leiden, the Netherlands; and.
Weidanz J; Abexxa Biologics, Inc., Arlington, TX; .; College of Nursing and Health Innovation, The University of Texas at Arlington, Arlington, TX.
Pokaż więcej
Źródło :
Journal of immunology (Baltimore, Md. : 1950) [J Immunol] 2022 May 01; Vol. 208 (9), pp. 2246-2255. Date of Electronic Publication: 2022 Apr 13.
Typ publikacji :
Journal Article
MeSH Terms :
Histocompatibility Antigens Class I*
Killer Cells, Natural*
Animals ; Antibodies/metabolism ; Mice ; NK Cell Lectin-Like Receptor Subfamily C/metabolism ; Peptides ; Receptors, Antigen, T-Cell/metabolism
Czasopismo naukowe
Tytuł :
Peripheral blood natural killer cells in sarcoidosis are associated with early cardiac involvement.
Autorzy :
Vakrakou AG; Neuroimmunology Laboratory, 1st Department of Neurology, School of Medicine, Eginition Hospital, National and Kapodistrian University of Athens, Athens, Greece.; Immunology and Histocompatibility Department, Evangelismos Hospital, Athens, Greece.
Kolilekas L; 7th Pulmonary Dept, Athens Chest Hospital 'Sotiria', Athens, Greece.
Lama N; Research Unit of Radiology and Medical Imaging, 2nd Department of Radiology, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
Katsanos S; Department of Cardiology, Medical School, General University Hospital 'Attikon', National and Kapodistrian University of Athens, Athens, Greece.
Stratakos G; Respiratory Medicine Department, Athens Chest Hospital 'Sotiria' Medical School, National and Kapodistrian University of Athens, Athens, Greece.
Tsougos I; Department of Cardiology, Heart Failure and Preventive Cardiology Section, Ygeia Hospital, Athens, Greece.
Manali E; Pulmonary Medicine Department, Medical School, General University Hospital 'Attikon', National and Kapodistrian University of Athens, Athens, Greece.
Grigoriou E; Immunology and Histocompatibility Department, Evangelismos Hospital, Athens, Greece.
Psarra K; Immunology and Histocompatibility Department, Evangelismos Hospital, Athens, Greece.
Kilidireas C; Neuroimmunology Laboratory, 1st Department of Neurology, School of Medicine, Eginition Hospital, National and Kapodistrian University of Athens, Athens, Greece.; First Department of Neurology, Medical School, Aeginition Hospital, National and Kapodistrian University of Athens, Athens, Greece.
Papiris S; Pulmonary Medicine Department, Medical School, General University Hospital 'Attikon', National and Kapodistrian University of Athens, Athens, Greece.
Kelekis NL; Research Unit of Radiology and Medical Imaging, 2nd Department of Radiology, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
Gialafos EJ; Department of Cardiology, Medical School, General University Hospital 'Attikon', National and Kapodistrian University of Athens, Athens, Greece.; First Department of Neurology, Medical School, Aeginition Hospital, National and Kapodistrian University of Athens, Athens, Greece.
Pokaż więcej
Źródło :
European journal of clinical investigation [Eur J Clin Invest] 2022 May; Vol. 52 (5), pp. e13742. Date of Electronic Publication: 2022 Jan 17.
Typ publikacji :
Journal Article
MeSH Terms :
Killer Cells, Natural*/pathology
Sarcoidosis*/pathology
Female ; Flow Cytometry ; Humans
Czasopismo naukowe
Tytuł :
Defective NK cell expansion, cytotoxicity, and lack of ability to differentiate tumors from a pancreatic cancer patient in a long term follow-up: implication in the progression of cancer.
Autorzy :
Kaur K; Division of Oral Biology and Oral Medicine, School of Dentistry and Medicine, Los Angeles, CA, USA.
Ko MW; Division of Oral Biology and Oral Medicine, School of Dentistry and Medicine, Los Angeles, CA, USA.
Chen F; Division of Oral Biology and Oral Medicine, School of Dentistry and Medicine, Los Angeles, CA, USA.
Jewett A; Division of Oral Biology and Oral Medicine, School of Dentistry and Medicine, Los Angeles, CA, USA. .; The Jonsson Comprehensive Cancer Center, UCLA School of Dentistry and Medicine, 10833 Le Conte Ave., Los Angeles, CA, 90095, USA. .
Pokaż więcej
Źródło :
Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2022 May; Vol. 71 (5), pp. 1033-1047. Date of Electronic Publication: 2021 Sep 24.
Typ publikacji :
Journal Article
MeSH Terms :
Killer Cells, Natural*
Pancreatic Neoplasms*/diagnosis
Pancreatic Neoplasms*/pathology
Cross-Sectional Studies ; Cytotoxicity, Immunologic ; Humans ; Prospective Studies
SCR Disease Name :
Pancreatic Carcinoma
Czasopismo naukowe
Tytuł :
Advancing natural killer therapies against cancer.
Autorzy :
Narni-Mancinelli E; Aix Marseille Univ, CNRS, INSERM, CIML, Marseille, France. Electronic address: .
Vivier E; Aix Marseille Univ, CNRS, INSERM, CIML, Marseille, France; Innate Pharma Research Laboratories, Innate Pharma, Marseille, France; APHM, Hôpital de la Timone, Marseille-Immunopôle, Marseille, France.
Pokaż więcej
Źródło :
Cell [Cell] 2022 Apr 28; Vol. 185 (9), pp. 1451-1454.
Typ publikacji :
Journal Article
MeSH Terms :
Killer Cells, Natural*
Neoplasms*/pathology
Neoplasms*/therapy
Apoptosis ; Humans ; Immunotherapy, Adoptive ; Mitochondria/pathology
Czasopismo naukowe
Tytuł :
Augmenting NK cell-based immunotherapy by targeting mitochondrial apoptosis.
Autorzy :
Pan R; Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215, USA; Harvard Medical School, Boston, MA 02215, USA. Electronic address: .
Ryan J; Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215, USA; Harvard Medical School, Boston, MA 02215, USA.
Pan D; Harvard Medical School, Boston, MA 02215, USA; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215, USA.
Wucherpfennig KW; Harvard Medical School, Boston, MA 02215, USA; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215, USA.
Letai A; Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215, USA; Harvard Medical School, Boston, MA 02215, USA. Electronic address: .
Pokaż więcej
Źródło :
Cell [Cell] 2022 Apr 28; Vol. 185 (9), pp. 1521-1538.e18. Date of Electronic Publication: 2022 Apr 20.
Typ publikacji :
Journal Article
MeSH Terms :
Immunotherapy*
Killer Cells, Natural*
Neoplasms/*therapy
Apoptosis ; Neoplasms/pathology
Czasopismo naukowe
Tytuł :
CD45RA ILCs in human tissues represent a quiescent local reservoir for the generation of differentiated ILCs.
Autorzy :
Kokkinou E; Center for Infectious Medicine, Department of Medicine Huddinge, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden.
Pandey RV; Center for Hematology and Regenerative Medicine, Department of Medicine, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden.
Mazzurana L; Center for Infectious Medicine, Department of Medicine Huddinge, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden.
Gutierrez-Perez I; Center for Hematology and Regenerative Medicine, Department of Medicine, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden.
Tibbitt CA; Center for Infectious Medicine, Department of Medicine Huddinge, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden.
Weigel W; Center for Infectious Medicine, Department of Medicine Huddinge, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden.
Soini T; Center for Infectious Medicine, Department of Medicine Huddinge, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden.
Carrasco A; Center for Infectious Medicine, Department of Medicine Huddinge, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden.
Rao A; Center for Infectious Medicine, Department of Medicine Huddinge, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden.
Nagasawa M; Department of Experimental Immunology, Amsterdam UMC, Location AMC, University of Amsterdam, Amsterdam, Netherlands.
Bal SM; Department of Experimental Immunology, Amsterdam UMC, Location AMC, University of Amsterdam, Amsterdam, Netherlands.
Jangard M; ENT Unit, Sophiahemmet University Research Laboratory and Sophiahemmet Hospital, Stockholm, Sweden.
Friberg D; Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.
Lindforss U; Department of Molecular Medicine and Surgery, Karolinska Institutet and Department of Pelvic Cancer, GI Oncology and Colorectal Surgery Unit, Karolinska University Hospital, Stockholm, Sweden.
Nordenvall C; Department of Molecular Medicine and Surgery, Karolinska Institutet and Department of Pelvic Cancer, GI Oncology and Colorectal Surgery Unit, Karolinska University Hospital, Stockholm, Sweden.
Ljunggren M; Department of Molecular Medicine and Surgery, Karolinska Institutet and Department of Pelvic Cancer, GI Oncology and Colorectal Surgery Unit, Karolinska University Hospital, Stockholm, Sweden.
Haapaniemi S; Department of Surgery, Vrinnevi Hospital, Norrköping, Sweden.; Department of Surgery, Linköping University, Linköping, Sweden.
Keita ÅV; Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.
Söderholm J; Department of Surgery, Linköping University, Linköping, Sweden.; Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.
Hedin C; Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.; Gastroenterology Unit, Department of Gastroenterology, Dermatovenereology and Rheumatology, Karolinska University Hospital, Stockholm, Sweden.
Spits H; Department of Experimental Immunology, Amsterdam UMC, Location AMC, University of Amsterdam, Amsterdam, Netherlands.
Bryceson YT; Center for Hematology and Regenerative Medicine, Department of Medicine, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden.
Mjösberg J; Center for Infectious Medicine, Department of Medicine Huddinge, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden.
Pokaż więcej
Źródło :
Science immunology [Sci Immunol] 2022 Apr 15; Vol. 7 (70), pp. eabj8301. Date of Electronic Publication: 2022 Apr 15.
Typ publikacji :
Journal Article
MeSH Terms :
Immunity, Innate*
Killer Cells, Natural*
Cell Differentiation ; Humans ; Inflammation ; Lymphocyte Activation
Czasopismo naukowe
Tytuł :
Primary CD33-targeting CAR-NK cells for the treatment of acute myeloid leukemia.
Autorzy :
Albinger N; Childrens Hospital, Experimental Immunology, Johann Wolfgang Goethe University, Frankfurt am Main, Germany.; Frankfurt Cancer Institute, Johann Wolfgang Goethe University, Frankfurt am Main, Germany.; University Cancer Center (UCT) Frankfurt, Frankfurt am Main, Germany.
Pfeifer R; Miltenyi Biotec B.V. & Co. KG, Bergisch Gladbach, Germany.
Nitsche M; Miltenyi Biotec B.V. & Co. KG, Bergisch Gladbach, Germany.
Mertlitz S; Charité, Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Department of Hematology, Oncology and Tumorimmunology, Berlin, Germany.
Campe J; Childrens Hospital, Experimental Immunology, Johann Wolfgang Goethe University, Frankfurt am Main, Germany.; Frankfurt Cancer Institute, Johann Wolfgang Goethe University, Frankfurt am Main, Germany.; University Cancer Center (UCT) Frankfurt, Frankfurt am Main, Germany.
Stein K; Childrens Hospital, Experimental Immunology, Johann Wolfgang Goethe University, Frankfurt am Main, Germany.; Frankfurt Cancer Institute, Johann Wolfgang Goethe University, Frankfurt am Main, Germany.; University Cancer Center (UCT) Frankfurt, Frankfurt am Main, Germany.
Kreyenberg H; Division for Stem Cell Transplantation, Immunology, and Intensive Care Medicine, Department for Children and Adolescents, University Hospital, Johann Wolfgang Goethe University, Frankfurt am Main, Germany.
Schubert R; Childrens Hospital, Pulmology and Allergology, Johann Wolfgang Goethe University, Frankfurt am Main, Germany.
Quadflieg M; Miltenyi Biotec B.V. & Co. KG, Bergisch Gladbach, Germany.
Schneider D; Lentigen Technology, Inc., a Miltenyi Biotec Company, Gaithersburg, MD, USA.
Kühn MWM; Department of Hematology, Medical Oncology, and Pulmonary Medicine, University Medical Center, Johannes Gutenberg-University, Mainz, Germany.
Penack O; Charité, Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Department of Hematology, Oncology and Tumorimmunology, Berlin, Germany.; German Cancer Consortium (DKTK), partner site Berlin and German Cancer Research Center (DKFZ), Heidelberg, Germany.
Zhang C; Miltenyi Biotec B.V. & Co. KG, Bergisch Gladbach, Germany.
Möker N; Miltenyi Biotec B.V. & Co. KG, Bergisch Gladbach, Germany.
Ullrich E; Childrens Hospital, Experimental Immunology, Johann Wolfgang Goethe University, Frankfurt am Main, Germany. .; Frankfurt Cancer Institute, Johann Wolfgang Goethe University, Frankfurt am Main, Germany. .; University Cancer Center (UCT) Frankfurt, Frankfurt am Main, Germany. .; German Cancer Consortium (DKTK) partner site Frankfurt/Mainz and German Cancer Research Center (DKFZ), Heidelberg, Germany. .
Pokaż więcej
Źródło :
Blood cancer journal [Blood Cancer J] 2022 Apr 13; Vol. 12 (4), pp. 61. Date of Electronic Publication: 2022 Apr 13.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Killer Cells, Natural*
Leukemia, Myeloid, Acute*/genetics
Leukemia, Myeloid, Acute*/therapy
Animals ; Cell Line, Tumor ; Disease Models, Animal ; Hematopoiesis ; Humans ; Immunotherapy, Adoptive ; Mice ; Sialic Acid Binding Ig-like Lectin 3/genetics
Czasopismo naukowe
Tytuł :
Presence of Natural Killer B Cells in Simian Immunodeficiency Virus-Infected Colon That Have Properties and Functions Similar to Those of Natural Killer Cells and B Cells but Are a Distinct Cell Population.
Autorzy :
Cogswell A; Department of Microbial Pathogens and Immunity, Rush University Medical Centergrid.240684.c, Chicago, Illinois, USA.
Jo S; Department of Microbial Pathogens and Immunity, Rush University Medical Centergrid.240684.c, Chicago, Illinois, USA.
Ferguson N; Department of Microbial Pathogens and Immunity, Rush University Medical Centergrid.240684.c, Chicago, Illinois, USA.
Gupta K; Department of Microbial Pathogens and Immunity, Rush University Medical Centergrid.240684.c, Chicago, Illinois, USA.
Barker E; Department of Microbial Pathogens and Immunity, Rush University Medical Centergrid.240684.c, Chicago, Illinois, USA.
Pokaż więcej
Źródło :
Journal of virology [J Virol] 2022 Apr 13; Vol. 96 (7), pp. e0023522. Date of Electronic Publication: 2022 Mar 21.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms :
Killer Cells, Natural*/immunology
Simian Acquired Immunodeficiency Syndrome*
Simian Immunodeficiency Virus*/immunology
Animals ; CD8-Positive T-Lymphocytes/immunology ; Colon/cytology ; Colon/immunology ; Colon/virology ; Cytokines/metabolism ; Inflammation/pathology ; Macaca mulatta ; Receptors, Natural Killer Cell/metabolism
Czasopismo naukowe
Tytuł :
Combination Blockade of the IL6R/STAT-3 Axis with TIGIT and Its Impact on the Functional Activity of NK Cells against Prostate Cancer Cells.
Autorzy :
González-Ochoa S; Instituto Mexicano del Seguro Social (IMSS), Centro de Investigación Biomédica de Occidente (CIBO), División de Inmunología, Guadalajara, 44340, Jalisco, Mexico.; Universidad de Guadalajara, Centro Universitario de Ciencias de la Salud (CUCS), Programa de Doctorado en Ciencias Biomédicas Orientación Inmunología, Guadalajara, 44340, Jalisco, Mexico.
Tellez-Bañuelos MC; Universidad de Guadalajara, Centro Universitario de Ciencias de la Salud (CUCS), Programa de Doctorado en Ciencias Biomédicas Orientación Inmunología, Guadalajara, 44340, Jalisco, Mexico.; Universidad de Guadalajara, Centro Universitario de Ciencias Biológicas y Agropecuarias (CUCBA), Departamento de Biología Celular y Molecular, Las Agujas, 45220, Jalisco, Mexico.
Méndez-Clemente AS; Instituto Mexicano del Seguro Social (IMSS), Centro de Investigación Biomédica de Occidente (CIBO), División de Inmunología, Guadalajara, 44340, Jalisco, Mexico.; Universidad de Guadalajara, Centro Universitario de Ciencias de la Salud (CUCS), Programa de Doctorado en Ciencias Biomédicas Orientación Inmunología, Guadalajara, 44340, Jalisco, Mexico.
Bravo-Cuellar A; Instituto Mexicano del Seguro Social (IMSS), Centro de Investigación Biomédica de Occidente (CIBO), División de Inmunología, Guadalajara, 44340, Jalisco, Mexico.; Universidad de Guadalajara, Centro Universitario de los Altos (CUALTOS), Departamento de Ciencias de la Salud, Tepatitlán de Morelos, 47620, Jalisco, Mexico.
Hernández Flores G; Instituto Mexicano del Seguro Social (IMSS), Centro de Investigación Biomédica de Occidente (CIBO), División de Inmunología, Guadalajara, 44340, Jalisco, Mexico.
Palafox-Mariscal LA; Instituto Mexicano del Seguro Social (IMSS), Centro de Investigación Biomédica de Occidente (CIBO), División de Inmunología, Guadalajara, 44340, Jalisco, Mexico.; Universidad de Guadalajara, Centro Universitario de Ciencias de la Salud (CUCS), Programa de Doctorado en Ciencias Biomédicas Orientación Inmunología, Guadalajara, 44340, Jalisco, Mexico.
Haramati J; Universidad de Guadalajara, Centro Universitario de Ciencias de la Salud (CUCS), Programa de Doctorado en Ciencias Biomédicas Orientación Inmunología, Guadalajara, 44340, Jalisco, Mexico.; Universidad de Guadalajara, Centro Universitario de Ciencias Biológicas y Agropecuarias (CUCBA), Departamento de Biología Celular y Molecular, Las Agujas, 45220, Jalisco, Mexico.
Pedraza-Brindis EJ; Universidad de Guadalajara, Centro Universitario de Ciencias de la Salud (CUCS), HIV and Immunodeficiencies Research Institute, Clinical Medicine Department, Guadalajara, 44280, Jalisco, Mexico.; Universidad Autónoma de Guadalajara, Departamento Académico de Aparatos y Sistemas I, Unidad Académica de Ciencias de la Salud, Zapopan, 45129, Jalisco, Mexico.
Sánchez-Reyes K; Universidad de Guadalajara, Centro Universitario de Ciencias de la Salud (CUCS), HIV and Immunodeficiencies Research Institute, Clinical Medicine Department, Guadalajara, 44280, Jalisco, Mexico.
Ortiz-Lazareno PC; Instituto Mexicano del Seguro Social (IMSS), Centro de Investigación Biomédica de Occidente (CIBO), División de Inmunología, Guadalajara, 44340, Jalisco, Mexico.; Universidad de Guadalajara, Centro Universitario de Ciencias de la Salud (CUCS), Programa de Doctorado en Ciencias Biomédicas Orientación Inmunología, Guadalajara, 44340, Jalisco, Mexico.
Pokaż więcej
Źródło :
Journal of immunology research [J Immunol Res] 2022 Apr 12; Vol. 2022, pp. 1810804. Date of Electronic Publication: 2022 Apr 12 (Print Publication: 2022).
Typ publikacji :
Journal Article
MeSH Terms :
Killer Cells, Natural*/metabolism
Prostatic Neoplasms*/metabolism
Humans ; Male ; Prostate/metabolism ; Receptors, Immunologic/metabolism ; Receptors, Interleukin-6
Czasopismo naukowe
Tytuł :
Differential regulation of transcription factor T-bet induction during NK cell development and T helper-1 cell differentiation.
Autorzy :
Fang D; Molecular and Cellular Immunoregulation Section, Laboratory of Immune System Biology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA. Electronic address: .
Cui K; Laboratory of Epigenome Biology, National Heart Lung and Blood Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Cao Y; Laboratory of Epigenome Biology, National Heart Lung and Blood Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Zheng M; Molecular and Cellular Immunoregulation Section, Laboratory of Immune System Biology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA; Department of Microbiology and Immunology School of Medicine, Jiangsu Provincial Key Laboratory of Critical Care Medicine, Southeast University, Nanjing, Jiangsu 210009, China.
Kawabe T; Immunobiology Section, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA; Department of Microbiology and Immunology, Tohoku University Graduate School of Medicine, Sendai 980-8575, Japan.
Hu G; Laboratory of Epigenome Biology, National Heart Lung and Blood Institute, National Institutes of Health, Bethesda, MD 20892, USA; Department of Microbiology, Immunology and Cell Biology, School of Medicine, West Virginia University, Morgantown, WV 26506, USA.
Khillan JS; Mouse Genetics and Gene Modification Section, Comparative Medicine Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
Li D; Molecular and Cellular Immunoregulation Section, Laboratory of Immune System Biology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA; Department of Clinical Laboratory, the Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215004, China.
Zhong C; Molecular and Cellular Immunoregulation Section, Laboratory of Immune System Biology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA; Institute of Systems Biomedicine, School of Basic Medical Sciences, Peking University Health Science Center, Beijing 100191, China.
Jankovic D; Immunoparasitology Unit, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
Sher A; Immunobiology Section, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
Zhao K; Laboratory of Epigenome Biology, National Heart Lung and Blood Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Zhu J; Molecular and Cellular Immunoregulation Section, Laboratory of Immune System Biology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA. Electronic address: .
Pokaż więcej
Źródło :
Immunity [Immunity] 2022 Apr 12; Vol. 55 (4), pp. 639-655.e7. Date of Electronic Publication: 2022 Apr 04.
Typ publikacji :
Journal Article
MeSH Terms :
Immunity, Innate*
Interleukin-18*/metabolism
Killer Cells, Natural*/immunology
Th1 Cells*/immunology
Cell Differentiation ; T-Box Domain Proteins/metabolism ; Transcription Factors/metabolism
Czasopismo naukowe
Tytuł :
Neutrophil and natural killer cell imbalances prevent muscle stem cell-mediated regeneration following murine volumetric muscle loss.
Autorzy :
Larouche JA; Department of Biomedical Engineering, University of Michigan, Ann Arbor, MI 48109.; Biointerfaces Institute, University of Michigan, Ann Arbor, MI 48109.
Fraczek PM; Department of Biomedical Engineering, University of Michigan, Ann Arbor, MI 48109.; Biointerfaces Institute, University of Michigan, Ann Arbor, MI 48109.
Kurpiers SJ; Department of Biomedical Engineering, University of Michigan, Ann Arbor, MI 48109.
Yang BA; Department of Biomedical Engineering, University of Michigan, Ann Arbor, MI 48109.; Biointerfaces Institute, University of Michigan, Ann Arbor, MI 48109.
Davis C; Department of Molecular & Integrative Physiology, University of Michigan, Ann Arbor, MI 48109.
Castor-Macias JA; Department of Biomedical Engineering, University of Michigan, Ann Arbor, MI 48109.; Biointerfaces Institute, University of Michigan, Ann Arbor, MI 48109.
Sabin K; Department of Biomedical Engineering, University of Michigan, Ann Arbor, MI 48109.; Biointerfaces Institute, University of Michigan, Ann Arbor, MI 48109.
Anderson S; Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, GA 30332.
Harrer J; Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, GA 30332.
Hall M; Department of Biomedical Engineering, University of Michigan, Ann Arbor, MI 48109.
Brooks SV; Department of Biomedical Engineering, University of Michigan, Ann Arbor, MI 48109.; Department of Molecular & Integrative Physiology, University of Michigan, Ann Arbor, MI 48109.
Jang YC; Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, GA 30332.; School of Biological Sciences, Georgia Institute of Technology, Atlanta, GA 30332.
Willett N; Phil and Penny Knight Campus for Accelerating Scientific Impact, University of Oregon, Eugene, OR 97403.
Shea LD; Department of Biomedical Engineering, University of Michigan, Ann Arbor, MI 48109.
Aguilar CA; Department of Biomedical Engineering, University of Michigan, Ann Arbor, MI 48109.; Biointerfaces Institute, University of Michigan, Ann Arbor, MI 48109.; Program in Cellular and Molecular Biology, University of Michigan, Ann Arbor, MI 48109.
Pokaż więcej
Źródło :
Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2022 Apr 12; Vol. 119 (15), pp. e2111445119. Date of Electronic Publication: 2022 Apr 04.
Typ publikacji :
Journal Article
MeSH Terms :
Killer Cells, Natural*/immunology
Muscle, Skeletal*/immunology
Muscle, Skeletal*/pathology
Muscular Diseases*/immunology
Muscular Diseases*/pathology
Neutrophils*/immunology
Regeneration*/immunology
Satellite Cells, Skeletal Muscle*/immunology
Animals ; Fibrosis ; Mice ; Neutrophil Infiltration ; Transforming Growth Factor beta/metabolism
Czasopismo naukowe
Tytuł :
ILC killer: Qu'est-ce que c'est?
Autorzy :
Withers DR; Institute of Immunology and Immunotherapy, College of Medical and Dental Sciences, University of Birmingham, Birmingham B15 2TT, UK.
Hepworth MR; Lydia Becker Institute of Immunology and Inflammation, Division of Infection, Immunity and Respiratory Medicine, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.
Pokaż więcej
Źródło :
Science immunology [Sci Immunol] 2022 Apr 08; Vol. 7 (70), pp. eabo2159. Date of Electronic Publication: 2022 Apr 08.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Immunity, Innate*
Killer Cells, Natural*
Animals ; Mice
Czasopismo naukowe
Tytuł :
Cryopreserved PM21-Particle-Expanded Natural Killer Cells Maintain Cytotoxicity and Effector Functions In Vitro and In Vivo .
Autorzy :
Oyer JL; Burnett School of Biomedical Sciences, College of Medicine, University of Central Florida, Orlando, FL, United States.
Croom-Perez TJ; Burnett School of Biomedical Sciences, College of Medicine, University of Central Florida, Orlando, FL, United States.
Dieffenthaller TA; Burnett School of Biomedical Sciences, College of Medicine, University of Central Florida, Orlando, FL, United States.
Robles-Carillo LD; Burnett School of Biomedical Sciences, College of Medicine, University of Central Florida, Orlando, FL, United States.
Gitto SB; Burnett School of Biomedical Sciences, College of Medicine, University of Central Florida, Orlando, FL, United States.; Department of Pathology and Laboratory Medicine, Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States.
Altomare DA; Burnett School of Biomedical Sciences, College of Medicine, University of Central Florida, Orlando, FL, United States.
Copik AJ; Burnett School of Biomedical Sciences, College of Medicine, University of Central Florida, Orlando, FL, United States.
Pokaż więcej
Źródło :
Frontiers in immunology [Front Immunol] 2022 Apr 07; Vol. 13, pp. 861681. Date of Electronic Publication: 2022 Apr 07 (Print Publication: 2022).
Typ publikacji :
Journal Article; Multicenter Study
MeSH Terms :
Killer Cells, Natural*/metabolism
Neoplasms*/therapy
Animals ; Cryopreservation ; Humans ; Immunotherapy/methods ; Immunotherapy, Adoptive ; Mice
Czasopismo naukowe
Tytuł :
CHMP2A regulates tumor sensitivity to natural killer cell-mediated cytotoxicity.
Autorzy :
Bernareggi D; Department of Medicine, University of California San Diego, La Jolla, CA, USA.
Xie Q; Key Laboratory of Growth Regulation and Translational Research of Zhejiang Province, School of Life Sciences, Westlake University, Hangzhou, Zhejiang, China.; Westlake Laboratory of Life Sciences and Biomedicine, Hangzhou, Zhejiang, China.; Institute of Basic Medical Sciences, Westlake Institute for Advanced Study, Hangzhou, Zhejiang Province, China.
Prager BC; Department of Medicine, University of California San Diego, La Jolla, CA, USA.; Cleveland Clinic Lerner College of Medicine at Cleveland Clinic & Case Western Reserve University, Cleveland, OH, USA.
Yun J; Department of Medicine, University of California San Diego, La Jolla, CA, USA.
Cruz LS; Department of Medicine, University of California San Diego, La Jolla, CA, USA.
Pham TV; Center for Novel Therapeutics and Moores Cancer Center, UCSD, San Diego, CA, USA.
Kim W; Center for Novel Therapeutics and Moores Cancer Center, UCSD, San Diego, CA, USA.; Division of Medical Genetics, Department of Medicine, Moores Cancer Center, University of California San Diego, La Jolla, CA, USA.
Lee X; Department of Oncology, Henan Provincial People's Hospital, Zhengzhou University People's Hospital, Zhengzhou, Henan, China.
Coffey M; Department of Medicine, University of California San Diego, La Jolla, CA, USA.
Zalfa C; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA.
Azmoon P; Department of Pathology, University of California San Diego, La Jolla, CA, USA.
Zhu H; Department of Medicine, University of California San Diego, La Jolla, CA, USA.
Tamayo P; Center for Novel Therapeutics and Moores Cancer Center, UCSD, San Diego, CA, USA.; Division of Medical Genetics, Department of Medicine, Moores Cancer Center, University of California San Diego, La Jolla, CA, USA.
Rich JN; Department of Medicine, University of California San Diego, La Jolla, CA, USA.
Kaufman DS; Department of Medicine, University of California San Diego, La Jolla, CA, USA. .
Pokaż więcej
Źródło :
Nature communications [Nat Commun] 2022 Apr 07; Vol. 13 (1), pp. 1899. Date of Electronic Publication: 2022 Apr 07.
Typ publikacji :
Journal Article
MeSH Terms :
Head and Neck Neoplasms*/genetics
Killer Cells, Natural*
Animals ; Apoptosis/genetics ; Cell Line, Tumor ; Cytotoxicity, Immunologic ; Endosomal Sorting Complexes Required for Transport ; Humans ; Immunotherapy ; Mice ; Squamous Cell Carcinoma of Head and Neck/genetics
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies